HIV/AIDS

Transition to new antiretrovirals in HIV programmes

Policy brief

Authors:
WHO

Policy brief: Transition to new antiretrovirals in HIV programmes

Publication details

Number of pages: 8
Publication date: July 2017
Languages: English
WHO reference number: WHO/HIV/2017.20

Downloads

Overview

This policy brief provides advice on a phased approach to transitioning to new WHO-recommended HIV treatment regimens. The target audience includes country HIV programme managers, procurement agencies, implementing partners, and other relevant parties.

The aim of this document is to ensure a continuous supply of antiretroviral (ARV) drugs, safely, rapidly and efficiently implement the 2016 WHO consolidated ARV guidelines and enable a smooth transition to optimized ARV regimens.

Related links